Increase CD24+CD27+ B cells within pleural effusions derived from lung adenocarcinoma presents enhanced potential for clinical utility
Immunobiology · 2025-09 · 230 (5) · 153109
DOI: 10.1016/j.imbio.2025.153109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunobiology, 2025-09. Verfasst von Yueming Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Respiratory Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Pleural Effusion, Malignant, B-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
BACKGROUND: The increasing interest in the roles of B cells, particularly regulatory B cells, within the tumor microenvironment has become prominent, though their immunological characteristics in malignant pleural effusions (PE) remain poorly elucidated. METHODS: Flow cytometry was performed in 143 pleural effusion and peripheral blood samples from patients in order to analyze the proportions ofPB-derived B and T cells, and to assess surface markers and cytokines, such as IFN-γ and IL-10. Moreover, we compared clinical role of CD24+CD27+B cell populations. RESULTS: B cell populations were significantly higher in PE from lung adenocarcinoma (LUAD)than tuberculosis (TB). Compared to PB from patients, the proportion of CD24+CD27+ B cells was markedly elevated in LUAD-PE and exhibited reduced levels of CD38, CD5, CD71,PD-1, and PD-L1, as well as an upregulation of IL-10 and CD39. PD-1 and PD-L1 werelargely found to be upregulated within the CD27+CD38+ B cell subset despite declining proportions overall. Re-interpretations illustrated significant relationshipsbetween CD24+CD27+ B cells and clinical measurements. CONCLUSIONS: This study highlights the heterogenicphenotypes and functions of various B cell subsets in LUAD-PE, with specific attention to CD24+CD27+ B cells as potential diagnostic markers and the need for further studies investigating their immunoregulatory functions to unveil new immunotherapeutic strategies in lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Respiratory Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical, Sciences, Southern Medical University, Guangzhou, Guangdong,…
- Institute of Translational Medicine, The First People's Hospital of Foshan, Foshan, Guangdong, China.
- Department of Respiratory and Critical Care Medicine, The First People's Hospital of Foshan, Foshan, Guangdong, China.
- Institute of Translational Medicine, The First People's Hospital of Foshan, Foshan, Guangdong, China. Electronic address: ysf@fsyyy.com.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Liang, Y., Sun, D., Xu, Q., Mao, X., Li, M., Gao, X., & Yu, S. (2025). Increase CD24+CD27+ B cells within pleural effusions derived from lung adenocarcinoma presents enhanced potential for clinical utility. Immunobiology, 230(5), 153109. https://doi.org/10.1016/j.imbio.2025.153109
Vancouver
Liang Y, Sun D, Xu Q, Mao X, Li M, Gao X, et al. Increase CD24+CD27+ B cells within pleural effusions derived from lung adenocarcinoma presents enhanced potential for clinical utility. Immunobiology. 2025;230(5):153109. doi:10.1016/j.imbio.2025.153109
BibTeX
@article{Liang2025,
author = {Liang, Yueming and Sun, Danqi and Xu, Qizhi and Mao, Xiaofan and Li, Minjing and Gao, XingLin and Yu, Sifei},
title = {Increase CD24+CD27+ B cells within pleural effusions derived from lung adenocarcinoma presents enhanced potential for clinical utility},
journal = {Immunobiology},
year = {2025},
volume = {230},
number = {5},
pages = {153109},
doi = {10.1016/j.imbio.2025.153109}
}
EUVIMED